Canyam
AI summaries for academic research
Home
Literature Help
Subscribe
Favorites
Tools
Analysis
Summary
Patents
Not logged in
Back
Journal Details
DARU-Journal of Pharmaceutical Sciences
IF
2.1
Papers
56
Citations
2204
Related Insights
0
subscribe
Journal Papers
56
Related Insights
0
Journal Papers
56
Publication Date
Publication Date
IF
Citations
Neurotensin modulation of immune and oxido-inflammatory homeostasis targeting TGF-β activated kinase 1/Nuclear factor-kappa βeta pathway: an integrated in vivo and in silico study
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-10-12
0
PRE
AI
Swarnima Mishra; Banalata Mohanty
Share
Save
Sodium oxybate for excessive daytime sleepiness in narcolepsy: a systematic review and meta-analysis of randomized placebo-controlled trials
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-10-05
0
PRE
AI
Preeti Kanawjia; Surendra Kumar Kanaujia; Renu Kumari
Share
Save
Emerging nanostructured platforms for improved oral delivery of antidiabetic agents: overcoming physiological barriers and enhancing therapeutic efficacy
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-10-05
0
PRE
AI
Shweta Yadav; Prashant Singh; Madhusudan Purohit; Shashikant Singh; Shobha Singh
Share
Save
Pharmacomicrobiomics-driven targeted drug delivery for precision microbiome modulation
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-10-05
0
PRE
AI
Anurag Biswas; Bijoy Ghosh; Pallvi Kumari; Ankita Rangra; Kaunava Roy Chowdhury; Akshay Kumar
Share
Save
BAY-876 restores lenvatinib sensitivity in resistant hepatocellular carcinoma cells by disrupting the GLUT1–SLC7A11–NADPH redox axis
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-10-05
0
PRE
AI
Ranran Xue; Ying Lin
Share
Save
Effects of rosehip (Rosa canina) supplementation on orthostatic intolerance symptoms in patients with type 2 diabetes: a randomized double-blind placebo-controlled clinical trial
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-10-05
0
PRE
AI
Seyed Yaser Ghelmani; Seyede Hamide Rajaie; Roghayeh Zare; Narjes Hazar; Ali khiveh; Morteza Zaboli Mahdiabadi; Seyed Hamdollah Mosavat; Morvarid Salamati; Majid Emtiazy; Mohammad Hashem Hashempur
Share
Save
Yiqi Guben capsule alleviates asthmatic airway inflammation through the miR-34a-5p/Notch1 pathway associated with Treg/Th17 immune balance
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-09-29
0
PRE
AI
Yinan Guo; Yibu Kong; Aiai Dong; Yue Shao; Xinyan Yu; Jinguang Zhao; Shuang Zu; Hao Yue; Anning Li; Yongji Wang; Liping Sun
Share
Save
Targeting neurovascular dysfunction in diabetic neuropathic pain: a review of mechanism-based pharmacotherapy beyond gabapentinoids
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-09-29
0
PRE
AI
Abhishek Kumar; Aman Shrivastava; Vinay Kumar; Paras Gupta; Rakesh Barik; Abhishek Dwivedi; Prerna Chaturvedi; Kuldeep Upadhayay; Sumeet Dwivedi; Jeetendra Kumar Gupta
Share
Save
Colistin therapy and survival outcomes in neonatal carbapenem-resistant gram-negative sepsis
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-09-29
0
PRE
AI
Seyyed Mohammad Hassan Aletayeb; Masoud Dehdashtian; Arash Malakian; Mohammad Reza Aramesh
Share
Save
Personalized neoantigen mRNA vaccines for pancreatic cancer: the role of lipid nanoparticle delivery systems
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-09-21
0
PRE
AI
Dipayan Debnath
Share
Save
Technology profiles in FDA-approved new molecular entities, 2013–2024: a latent class analysis
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-09-21
0
PRE
AI
Soon Kyu Jung
Share
Save
Therapy resistance-related ncRNAs in cervical cancer: biomarkers and therapeutic targets
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-09-21
0
PRE
AI
Lili Liu; Limei Zhang; Zhe Ma
Share
Save
Important potential risks not reflected in Japanese drug labeling: implications for risk management plan termination
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-09-18
0
OA
AI
Natsuko Kameyama; Ayana Ide; Hideki Maeda
Share
Save
Acetaminophen-induced acute liver injury abrogates the cytosine methylation pathway
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-09-17
0
PRE
AI
Dilkash Ara; Bathula Ziona; Sathish Kumar Mungamuri
Share
Save
Prasugrel in the management of acute coronary syndromes: a systematic review
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-09-17
0
PRE
AI
Canan Akman; Asli Bahar Ucar; Mehmet Unaldi; Gul Kilic; Busra Erdem; Pinar Vargun; Sennaz Sahin; Bilgen Ozkaya; Ozgur Karcioglu
Share
Save
Development of nanoemulsion-based in situ gel formulation of escitalopram oxalate for intranasal delivery in depression therapy
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-09-16
0
PRE
AI
Vahid Vikram Minglani; Meenakshi B. Patel; Tarun Kumar Upadhyay
Share
Save
Artificial intelligence-driven digital twins in Pharma 4.0: transforming smart manufacturing, predictive quality assurance, and personalized drug delivery
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-09-16
0
PRE
AI
Chetana Krushna Belkare; Omkar Vishnu Daware
Share
Save
Quercetin-loaded invasomal gel: preparation, optimization, in vitro evaluation and ex vivo skin permeation evaluation
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-09-11
0
PRE
AI
Janavi Sosa; Prachi Pimple
Share
Save
Terpenoids as modulators of autophagy-senescence crosstalk in lung cancer
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-09-11
0
PRE
AI
Kambati Niharika; Nagakanni Muthuvenugopal; Mamali Das; Chandramohan Kiruthiga
Share
Save
From triggers to interfaces: polymer-stabilized nano-co-crystals for robust mesalazine delivery in UC.
DARU-Journal of Pharmaceutical Sciences
IF
2.1
2026-09-10
0
PRE
AI
Arif khan; Sandeep Kumar; Anil Rajnath Singh; Mohit Agarwal; Arun Kailasiya; Junaid Qureshi
Share
Save